 Shares of Eloxx Pharmaceuticals OTCMKTS:ELOX have earned a consensus recommendation of Buy from the six ratings firms that are covering the company, Marketbeat reports. Two investment analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average 12 month target price among brokerages that have ... 